Based on what we found previously that VA is a potential HDAC inhibitor which holds multiple anti-cancer effects for liver and breast cancer [10, 11], the effects of VA on prostate cancer seem also more intriguing. The gene discussed is HDAC9; the disease is prostate carcinoma.